416 results
Page 4 of 21
8-K
EX-10.1
099y dm8gxkejxi6
25 Jan 21
Caladrius Biosciences Announces $25.0 Million Private Placement
4:01pm
8-K
EX-10.2
e5bvyhts
25 Jan 21
Caladrius Biosciences Announces $25.0 Million Private Placement
4:01pm
8-K
up3nmks wqvy0cfhzk
5 Nov 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 Third Quarter Financial Results
4:09pm
S-8
d52cjnj 9bhnvbw7
18 Aug 20
Registration of securities for employees
4:05pm
8-K
d980t 7i8
28 Jul 20
Caladrius Biosciences Appoints Dr. Michael H. Davidson
8:24am
8-K
EX-10.1
j67o8 cy04x
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
424B3
dmn4fmg114486
29 Jun 20
Prospectus supplement
12:00am
424B5
4gbrg8
26 May 20
Prospectus supplement for primary offering
4:02pm
8-K
EX-10.1
og3c5fm1oh0ilega
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
424B5
w82b84i7vmpjnyh5yh3
27 Apr 20
Prospectus supplement for primary offering
7:30am
8-K
EX-10.1
lgy7bqix
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm